The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Order Print Edition


Blenrep (belantamab mafodotin-blmf) is an antibody-drug conjugate (ADC), the first in a new class of treatments for myeloma. Blenrep is the…
This publication discusses what myeloma patients should consider if enrolling in a clinical trial.
This publication discusses the use of DARZALEX (daratumumab) injection and DARZALEX FASPRO —for the treatment of myeloma.
This publication discusses how to cope with fatigue caused by anemia and other factors related to the underlying disease.
This publication discusses the use of Freelite (serum free light chain assay) and Hevylite (serum heavy/light chain assay) tests for monitoring…

We Thank Our Sponsors:
BMS, GSK, Janssen, Karyopharm Therapeutics, Legend Biotech, Sanofi, and Takeda Pharmaceuticals U.S.A., Inc.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.